Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Respiratory insufficiency
MeSH D012131 - respiratory insufficiency
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D012120:
Respiration disorders
50 Companies
9 Drugs
$
Success rate
D012131:
Respiratory insufficiency
1 Company
1 Drug
$
Success rate
D000142:
Respiratory acidosis
0 Companies
0 Drugs
Success rate
D000402:
Airway obstruction
31 Companies
7 Drugs
$
Success rate
D006102:
Laryngeal granuloma
0 Companies
0 Drugs
Success rate
D007040:
Hypoventilation
18 Companies
3 Drugs
$
Success rate
D012133:
Respiratory paralysis
0 Companies
0 Drugs
Success rate
D018467:
Intrinsic positive-pressure respiration
0 Companies
0 Drugs
Success rate
D018804:
Hantavirus pulmonary syndrome
0 Companies
0 Drugs
Success rate
D057768:
Resolved brief unexplained event
0 Companies
0 Drugs
Success rate
D000097742:
Patient-ventilator asynchrony
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Linde Healthcare
Nitric oxide
INOmax
2001-08-01
Clinical Trials
Historical Success Rate
Phase 1
50
%
11/22
Phase 2
43
%
26/60
Phase 3
21
%
11/52
Approved:
1
Overall Success rate:
5%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use